Show items per page
Elements: 8
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Neurodegenerative cerebrospinal fluid biomarkers tau and amyloid beta predict functional, quality of life, and neuropsychological outcomes after aneurysmal subarachnoid hemorrhage Joswig, Holger; Korte, Wolfgang; Früh, Severin; Epprecht, Lorenz; ... Stienen, Martin 2018
add to browser selection
Clinical validity of cerebrospinal fluid Aβ42, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework Mattsson, Niklas; Lönneborg, Anders; Boccardi, Marina; Blennow, Kaj; Hansson, Oskar 2017
add to browser selection
Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology Tautvydaitė, D; Antonietti, J P; Henry, H; von Gunten, Armin; Popp, Julius 2017
add to browser selection
Les biomarqueurs du liquide céphalorachidien dans la maladie d’Alzheimer en pratique clinique courante Magnin, Eloi; Popp, Julius 2016
add to browser selection
Imagerie cérébrale de la maladie d’Alzheimer : état de l’art et perspectives pour le clinicien Trombella, Sara; Assal, Frédéric; Zekry Berger, Dina Selma; Gold, Gabriel; ... Frisoni, Giovanni 2016
add to browser selection
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study Ewers, Michael; Mattsson, Niklas; Minthon, Lennart; Molinuevo, José L; ... Hampel, Harald 2015
add to browser selection
Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type Popp, Julius; Wolfsgruber, Steffen; Heuser, Isabella; Peters, Oliver; ... Jessen, Frank 2015
add to browser selection
Alzheimer's CSF markers in older schizophrenia patients Frisoni, Giovanni; Prestia, Annapaola; Geroldi, Cristina; Adorni, Andrea; ... Giannakopoulos, Panteleimon 2011